The legacy of Viagra and the pharmaceutical industry presents a complex picture for potential investors. Initially, copyright's remarkable drug altered the treatment of erectile dysfunction, producing significant profits and defining the contemporary pharmaceutical landscape. However, patent expiration and the rise of off-brand versions have sharpl